MoneyWorks4Me

Trans Medicare informs about quarterly statement of investor complaint

18 Jan 2016 Evaluate

Trans Medicare has informed about quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.05
Dr. Reddys Labs. 1321.40
Cipla 1352.00
Lupin 1951.00
Zydus Lifesciences 1171.15
View more..